ACC: Mavacamten Cuts Need for Surgery in Hypertrophic Cardiomyopathy
MONDAY, April 11, 2022 -- For patients with obstructive hypertrophic cardiomyopathy (HCM), mavacamten improves symptoms and reduces the need for septal reduction therapy (SRT), according to a study presented at the annual meeting of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 11, 2022 Category: Pharmaceuticals Source Type: news

AI mines MRI to predict future death from cardiac arrest
An artificial intelligence (AI) algorithm can predict from a patient's raw M...Read more on AuntMinnie.comRelated Reading: Cardiac MRI predicts heart failure risk in cardiomyopathy patients CAC scores predict cardiac risk in patients with high cholesterol Does higher risk of heart disease always translate to cardiac events? AI can add value in all parts of MR imaging chain (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 7, 2022 Category: Radiology Source Type: news

Migraines May Affect Outcomes in Takotsubo Cardiomyopathy
TUESDAY, April 5, 2022 -- Patients with Takotsubo cardiomyopathy (TCM), which is typically due to a neurocardiogenic mechanism, with migraine have lower odds of mortality and acute complications compared with TCM patients without migraine, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2022 Category: Pharmaceuticals Source Type: news

Baby girl with rare heart condition finally receives a successful transplant 
Elodie Baker, who is under one year old, received a successful heart transplant on March 27. She was diagnosed with dilated cardiomyopathy, a rare but dangerous heart condition last year. (Source: the Mail online | Health)
Source: the Mail online | Health - April 4, 2022 Category: Consumer Health News Source Type: news

Mavacamten Controlled Hypertrophic Cardiomyopathy for > 1 Year Mavacamten Controlled Hypertrophic Cardiomyopathy for > 1 Year
Open-label mavacamten for a median of 62 weeks in patients with symptomatic obstructive hypertrophic cardiomyopathy showed ongoing safety and efficacy.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 4, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

VALOR-HCM: Novel Drug May Delay, Avert Invasive Therapy in OHCM VALOR-HCM: Novel Drug May Delay, Avert Invasive Therapy in OHCM
A medical alternative to highly invasive septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy and symptoms despite standard meds? Perhaps, a randomized trial suggests.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 2, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

Add-On Mavacamten Cuts Need for Septal Reduction in Obstructive HCM
(MedPage Today) -- WASHINGTON – Treatment with investigational mavacamten allowed patients with advanced obstructive hypertrophic cardiomyopathy (oHCM) to avoid septal reduction therapies (SRT), a researcher reported. In the VALOR-HCM study... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - April 2, 2022 Category: Surgery Source Type: news

Ischemic-Pattern LGE in Idiopathic Dilated Cardiomyopathy Might Not Reflect Ischemia Ischemic-Pattern LGE in Idiopathic Dilated Cardiomyopathy Might Not Reflect Ischemia
A significant proportion of patients with idiopathic dilated cardiomyopathy and LGE-CMR had no evidence of obstructive coronary artery disease on coronary angiography, investigators report.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - March 31, 2022 Category: Radiology Tags: Cardiology News Source Type: news

Obstructive HCM: Will Septal Reduction Zapping Hold Up?
(MedPage Today) -- Operators continued to make progress on an investigational septal reduction procedure for drug-refractory obstructive hypertrophic cardiomyopathy (HCM) at the Chinese center that pioneered the technique. Among 200 patients... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - March 30, 2022 Category: Surgery Source Type: news

New Tool Detects Difficult-to-Diagnose Cardiac Conditions New Tool Detects Difficult-to-Diagnose Cardiac Conditions
A new algorithm has been developed that can reliably detect two cardiovascular conditions -- hypertrophic cardiomyopathy and cardiac amyloidosis -- that are often difficult to diagnose.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 17, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

Cardiac MRI predicts heart failure risk in cardiomyopathy patients
Cardiac MRI appears to offer prognostic signs of heart failure in patients wit...Read more on AuntMinnie.comRelated Reading: Myocarditis induced by COVID-19-vaccine milder than that caused by other factors MRI spots myocarditis in young people vaccinated for COVID-19 Myocarditis linked to COVID-19 affects small number of athletes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 11, 2022 Category: Radiology Source Type: news

It's All Relative: How Much Dilated Cardiomyopathy Is Familial? It's All Relative: How Much Dilated Cardiomyopathy Is Familial?
A large, multicenter cohort study supports phenotype-based screening of first-degree family members of patients with confirmed DCM without input, necessarily, from genetic testing.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 8, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

Sex and race disparities found in management of patients with hypertrophic cardiomyopathy in the hospital
ROCHESTER, Minn. — In recent decades, implantable cardioverter-defibrillator (ICD) use in the management of patients with hypertrophic cardiomyopathy (HCM) has increased. However, a new Mayo Clinic study finds that ICDs are not used as often for female patients and patients of color. Data from the National Inpatie nt Sample, an all-payer administrative database of inpatient hospitalizations, showed disparities regarding which patients commonly receive this therapy in the hospital. The data also revealed regional variations in the… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 7, 2021 Category: Databases & Libraries Source Type: news

Acute heart failure due to aluminum phosphide poisoning - Petrovic M, Otero D, Leigh A, Singh V.
We present a case of severe reversible cardiomyopathy and left ventricular apical thrombus in a patient who worked as an exterminator and had ALP poisoning. ... (Source: SafetyLit)
Source: SafetyLit - November 29, 2021 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

Mayo Clinic Q & amp;A podcast: Justin's journey and silver linings
At the age of 15, Justin Vigile was diagnosed with hypertrophic cardiomyopathy, a genetic condition that causes the muscles of the heart to thicken, making it difficult for the heart to pump blood. Vigile had a cardiac defibrillator placed, but over time, his heart began to fail. When looking for answers and help, Vigile and his family turned to Mayo Clinic. Thanks to science, research and an innovative procedure performed by the man who developed… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 24, 2021 Category: Databases & Libraries Source Type: news